Jabra Enhance Select 200 vs Sony CRE-C20
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Jabra Enhance Select 200
The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earned a B grade with a SoundScore of 3.9/5 in our lab testing, placing it in the top 35% of the OTC hearing aid category. At $1,695, this behind-the-ear device offers solid performance in several key areas, though it faces stiff competition from higher-scoring alternatives at similar price points. In our testing, this device showed particular strength in speech clarity during quiet listening situations, scoring 3.5/5—0.67 points above the category average. Own-voice comfort was another highlight at 3.4/5, finishing 0.89 points above average, which suggests users may find their own voice sounds more natural compared to many competitors. Music streaming scored 2.6/5, which is above the category average by 0.68 points but still only mixed in absolute terms. The device's limitations become apparent in challenging listening environments. Speech in noise scored just 1.4/5, slightly below the category average and low in absolute terms—a consideration for users who frequently encounter noisy restaurants or social gatherings. Feedback handling scored 4.0/5, which is strong in absolute terms though 0.54 points below the category average. The Enhance Select 200 has earned Expert's Choice Awards in both 2023 and 2024, reflecting its reliable real-world performance. With Bluetooth streaming for both iPhone and Android, rechargeable batteries, and hands-free capability, it offers modern convenience features. However, shoppers should note that several competitors in this price range—including the Lucid Tala and Audicus Omni 2—scored notably higher in our testing. This device is best suited for users who prioritize speech clarity in quieter environments and own-voice comfort over performance in noisy situations.

Sony CRE-C20
The Sony CRE-C20 is a mid-priced OTC hearing aid with an invisible-in-ear design, available for $999. In our lab testing, it earned a B grade with a SoundScore of 3.5/5, ranking #37 of 65 OTC hearing aids tested. This device shows a notable split in performance. Speech clarity is a clear strength—speech in quiet scores 4.1/5, which is 1.33 points above the category average, and speech in noise scores 2.7/5, sitting 1.24 points above average despite being only mixed in absolute terms. These results suggest the CRE-C20 prioritizes conversational intelligibility in its tuning approach. However, the device has significant limitations. Music streaming scored 0.0/5, falling 1.92 points below the category average—a notable weakness for users who want to stream audio. Feedback handling is solid at 3.9/5, though it sits 0.64 points below the category average of 4.54/5. Own voice comfort is mixed at 2.9/5, slightly above the category average. The CRE-C20 responds well to adjustment, with the normalized score improving from 3.3/5 at initial fit to 4.2/5 when tuned—a 0.9-point gain. Buyers focused primarily on speech understanding in conversations may find value here, but those wanting music streaming or seeking the strongest overall OTC performance should note that several competitors in this price range, including the Sony CRE-E10 at 4.66/5, scored higher in our testing.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit